Response Evaluation after Stereotactic Ablative Radiotherapy for Lung Cancer
نویسنده
چکیده
229 Received 20 October 2015, Revised 7 November 2015, Accepted 9 November 2015 Correspondence: Ji Hoon Choi ([email protected]) Tel: 82-51-990-6399, Fax: 82-51-793-0660 cc This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Response Evaluation after Stereotactic Ablative Radiotherapy for Lung Cancer
منابع مشابه
Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer
BACKGROUND Limited data describe the prognosis after stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer. Thus, we evaluated treatment outcomes of stereotactic ablative radiotherapy for those patients. METHODS The study involved patients received stereotactic ablative radiotherapy for one to three lung metastases arising from colorectal cancer at a single ins...
متن کاملNon-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy.
Stereotactic ablative radiotherapy has emerged as a standard treatment for medically inoperable stage I non-small-cell lung cancer and selected cases of lung metastasis. Techniques to freeze or limit tumour movement during treatment and image-guided radiation delivery are integral to a successful stereotactic ablative treatment without overdose of surrounding normal structures. In this article,...
متن کاملStereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes.
OBJECTIVE. To evaluate the clinical outcome and safety of stereotactic ablative radiotherapy for medically inoperable stage I non-small-cell lung carcinoma. DESIGN. Retrospective case series. SETTING. Pamela Youde Nethersole Eastern Hospital, Hong Kong. PATIENTS. All patients with medically inoperable stage I non-small-cell lung carcinoma receiving stereotactic ablative radiotherapy since its e...
متن کاملStereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment of primary and secondary lung tumours is appraised, and key ongoing trials are identified.
متن کاملResponse to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer
Stereotactic ablative radiotherapy (SABR) is the main treatment for inoperable early-stage non-small cell lung cancer (NSCLC). Despite the widespread use of SABR, the biological determinants of response to SABR remain poorly investigated. We developed an orthotopic NSCLC animal model to study the response to clinically-relevant doses of SABR. Image-guided intra-thoracic injection of NSCLC cells...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016